Skip to main content
Premium Trial:

Request an Annual Quote

Grants as Ageism

The University of Maryland's Les Costello writes at The Scientist that NIH's initiative to support new investigators at the same rates as established investigators is a form of age discrimination. "As young investigators, I and my colleagues successfully competed with established researchers based on merit, without preferential treatment," he writes. "NIH states that in recent years young investigators have not competed successfully with established investigators, hence the need to downgrade the quality of science funded through the R01 research grant mechanism."

NIH has re-issued the call for the Director's Pioneer Awards and New Innovators Awards, The Scientist also reports. These awards for riskier research will provide $2.5 million to about 15 scientists and $1.5 million to over 30 researchers, respectively. The New Innovators Awards specifically target researchers who have yet to receive an R01 grant.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.